Clover Health Investments CLOV Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -2.6%-0.9pp | -4.4%-1.1pp | -3.3%+3.2pp | -2.6%— | -1.6%— | |
| Net margin | -2.6%-0.9pp | -4.4%-1.3pp | -3.3%+3.5pp | -2.7%— | -1.7%— | |
| EBITDA margin | -2.5%-1.0pp | -4.4%-1.1pp | -3.2%+3.2pp | -2.5%— | -1.5%— | |
| Returns | ||||||
| Return on equity | -16.9%-8.9pp | -26.3%-12.6pp | -17.1%+10.5pp | -12.9%+24.9pp | -8%+44.0pp | |
| Return on assets | -8.9%-4.9pp | -15.3%-7.8pp | -9.6%+4.0pp | -6.9%+11.1pp | -4%+18.7pp | |
| Efficiency | ||||||
| Asset turnover | 3.5×+1.1× | 3.4×+1.0× | 2.9×+0.9× | 2.6×— | 2.4×— | |
| Liquidity | ||||||
| Current ratio | 1.3×-0.2× | 1.5×-0.1× | 1.7×+0.2× | 1.8×+0.1× | 1.5×0.0× | |
| Quick ratio | 1.3×-0.2× | 1.5×-0.1× | 1.7×+0.2× | 1.8×+0.1× | 1.5×0.0× | |
| Cash ratio | 0.5×-0.2× | 0.4×-0.5× | 1×0.0× | 0.9×+0.1× | 0.7×+0.1× | |
| Per Share | ||||||
| Book value per share | $0.64-5.7% | $0.60-13.4% | $0.66-4.7% | $0.68+3.0% | $0.68+12.4% | |
| Valuation | ||||||
| Market capitalization | $923.41M-49.7% | $1.21B-23.1% | $1.57B+14.1% | $1.45B+142% | $1.83B+375% | |
| Price / sales | 0.4×-0.8× | 0.6×-0.5× | 0.9×-0.1× | 0.9×— | 1.2×— | |
| Price / book | 2.7×-2.7× | 3.9×-0.7× | 4.6×+0.6× | 4.2×+2.4× | 5.5×+4.1× | |
| Earnings yield | -6.2%-4.8pp | -7%-4.3pp | -3.7%+2.9pp | -3%+17.7pp | -1.4%+40.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Clover Health Investments's ratios come from?
- Every ratio is computed from Clover Health Investments's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
